It is not part of any FDA-approved drug formulation and has not been found safe or effective for any condition at this time
Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1
This can affect potency and effectiveness
Patients seeking GLP-1-based therapy have several evidence-based options available through prescription from licensed healthcare providers
These medications, which include semaglutide, tirzepatide, and liraglutide, often carry price tags of $1,000 or more per month at retail pharmacies without insurance or a discount card
They discuss how these drugs work, why muscle mass, not just body weight, is the true marker of health, and why many people who lose weight too quickly end up weaker, not healthier